|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | High level of concordance between assays for glutamic acid decarboxylase autibodies显示文摘 | Schmidli RS Colman PG Bonifacio E | 1995 | Diabetes1995，44，： | 1 |
| 2 | Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial 显示文摘 | Rajamani K Colman PG Li LP | 2009 | Lancet2009，373，9677： | 1 |
| 3 | The role of HbAlc in the diagnosis of diabetes mellitos in Australia显示文摘 | d'Emden MC Shaw JE Colman PG | 2012 | Med J Aust2012，197，4： | 1 |
| 4 | Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial显示文摘 | AC Keech P Mitchell PA Summanen J O'Day TME Davis MS Moffitt M-R Taskinen RJ Simes D Tse E Williamson A Merrifield LT Laatikainen MC d'Emden DC Crimet RL O'Connell PG Colman | 2007 | The Lancet2007，，9600： | 1 |
| 5 | Desirable performance standards for HbA(lc) analysis - precision, accuracy and standardisation: consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA)显示文摘 | Goodall I Colman PG Schneider HG | 2007 | Clin Chem Lab Med2007，45，8： | 1 |
| 6 | Desirable performance standards for HbA1c (1c) analysis-precision,accuracy and standardization:consensus statement of the Australasian Association of Clinical Biochemists (AACB),the Australian Diabetes Society (ADS),the Royal College of Pathologists of Australasia (RCPA),Endocrine Society of Australia (ESA),and the Australian Diabetes Educators Association (ADEA)显示文摘 | Goodall I Colman PG Schneider HG | 2007 | Clin Chem Lab Med2007，45，8： | 1 |
| 7 | Fluminant type 1 diabetes in Australia in the absence of humoral and cellular immune response to pancreati- cislet autoantigens显示文摘 | Lee I Harrison LC Colman PG | 2012 | Diabetes Res Clin Praet2012，95，1： | 1 |
| 8 | HLA genes associated with autoimmunity and progression to disease in type 1 diabetes 显示文摘 | TaitBD Colman PG Morahan G | 2003 | Tissue Antigens2003，61，2： | 1 |
| 9 | Desirable performance standards for HbA1c analysis-precision,accuracy and standardisation consensus statement of the Australasian Association of Clinical Biochemists(AACB),the Australian Diabetes Society(ADS),the Royal College of Pathologists of Australasia(RCPA),Endocrine Society of Australia(ESA),and the Australian Diabetes Educators Association(ADEA)显示文摘 | Goodall I Colman PG Schneider HG | 2007 | Clin Chem Lab Med2007，45，： | 1 |
| 10 | Measurement of islet cell antibodies in the Type I Diabetes Genetics Consortium:efforts to harmonize procedures among the laboratories显示文摘 | Bingley PJ Williams AJ Colman PG | 2010 | Clin Trials2010，7，1： | 1 |
| 11 | New classification and criteria for diagnosis of diabetes显示文摘 | Colman PG Thomas DW Zimmet PZ | 1999 | MJA1999，170，： | 1 |
| 12 | The accelerator hypothesis and increasing incidence of type 1 diabetes显示文摘 | Fourlanos S Harrison LC Colman PG | | 0，，： | 1 |
| 13 | FIELD study investigators effect of fenofibrate on amputation events in people with type 2 dia- betes mellitus ( FIELD study ) : a prespecified analysis of a randomised controlled trial 显示文摘 | RAJAMANI K COLMAN PG LIL P BEST JD VOYSEY M DEMDEN MC | 2009 | Lancet2009，373，9677： | 1 |
| 14 | Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relative at risk for IDDM显示文摘 | Schmidli RS Colman PG Harrison LC | 1994 | Autoimmunity1994，，7： | 1 |
| 15 | High level of concordance between assays for glutamic acid decarboxylase antibodies显示文摘 | Schmidli RS Colman PG Bonifacio E | 1995 | Diabetes1995，44，： | 1 |
| 16 | An evaluation of community-based resources for management of diabetes-related foot disorders in an Australian population 显示文摘 | Bergin SM Brand CA Colman PG | 2009 | Aust Health Rev2009，33，4： | 1 |
| 17 | Desirable performance standards for HbA ( l c ) analysis-precision, aeeuraey and standardisation: consensus statement of the Australasian Association of Clinical Biochemists ( AACB ) , the Australian Diabetes Society ( ADS), the Royal College of Pathologists of Australasia ( RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA) 显示文摘 | Goodall I Colman PG Schneider HG | 2007 | Clin Chem Lab Med2007，45，8： | 1 |
| 18 | New classification and criteria for diagnosis of diabetes mellitus 显示文摘 | Colman PG Thomas DW Zimmet PZ | 1999 | The Medical journal of Australia1999，170，8： | 1 |
| 19 | Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study):a prespecified analysis of a randomised controlled trial显示文摘 | Rajamani K Colman PG Li LP Best JD Voysey M D' Emden MC | | 0，，9677： | 1 |
| 20 | Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial显示文摘 | AC Keech P Mitchell PA Summanen J O’Day TME Davis MS Moffitt M-R Taskinen RJ Simes D Tse E Williamson A Merrifield LT Laatikainen MC d’Emden DC Crimet RL O’Connell PG Colman | 2007 | The Lancet . 2007 (9600)2007，，9600： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员